HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fogg, M. H. Articles by Kaur, A. Search for Related Content PubMed PubMed Citation Articles by Fogg, M. H. Articles by Kaur, A.

The BZLF1 Homolog of an Epstein-Barr-Related -Herpesvirus Is a Frequent Target of the CTL Response in Persistently Infected Rhesus Macaques¹

Mark H. Fogg^*, Deirdre Garry, Amany Awad, Fred Wang^* and Amitinder Kaur^2,

^* Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; and Department of Immunology, New England Primate Research Center, Harvard Medical School, Southborough, MA 01772

Although CD8⁺ T lymphocytes targeting lytic infection proteins dominate the immune response to acute and persistent EBV infection, their role in immune control of EBV replication is not known. Rhesus lymphocryptovirus (rhLCV) is a -herpesvirus closely related to EBV, which establishes persistent infection in rhesus macaques. In this study, we investigated cellular immune responses to the rhLCV BZLF1 (rhBZLF1) homolog in a cohort of rhLCV-seropositive rhesus macaques. rhBZLF1-specific IFN- ELISPOT responses ranging between 56 and 3070 spot-forming cells/10⁶ PBMC were detected in 36 of 57 (63%) rhesus macaques and were largely mediated by CD8⁺ T lymphocytes. The prevalence and magnitude of ELISPOT responses were greater in adult (5–15 years of age) rather than juvenile macaques (<5 years of age), suggesting that rhBZLF1-specific CTL increase over time following early primary infection. A highly immunogenic region in the carboxyl terminus of the rhBZLF1 protein containing overlapping CTL epitopes restricted by Mamu-A*01 and other as yet unidentified MHC class I alleles was identified. The presence of a robust CD8⁺ T lymphocyte response targeting this lytic infection protein in both rhesus macaques and humans suggests that these CTL may be important for immune control of EBV-related -herpesvirus infection. These data underscore the utility of the rhLCV-macaque model for studies of EBV pathogenesis.

This article has been cited by other articles:

				T. Strowig, C. Gurer, A. Ploss, Y.-F. Liu, F. Arrey, J. Sashihara, G. Koo, C. M. Rice, J. W. Young, A. Chadburn, et al. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components J. Exp. Med., June 8, 2009; 206(6): 1423 - 1434. [Abstract] [Full Text] [PDF]

				M. H. Fogg, L. J. Wirth, M. Posner, and F. Wang Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma PNAS, March 3, 2009; 106(9): 3318 - 3323. [Abstract] [Full Text] [PDF]

				Y.-J. Song, K. M. Izumi, N. P. Shinners, B. E. Gewurz, and E. Kieff IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3 PNAS, November 25, 2008; 105(47): 18448 - 18453. [Abstract] [Full Text] [PDF]